Clinical Trials Logo

Clinical Trial Details — Status: Suspended

Administrative data

NCT number NCT05207345
Other study ID # PG/2021/17872
Secondary ID
Status Suspended
Phase N/A
First received
Last updated
Start date February 1, 2022
Est. completion date December 30, 2024

Study information

Verified date November 2023
Source University of Cagliari
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Stroke is responsible for about 7% of disabilities in the European population. Intracerebral hemorrhage (ICH) represents 15% of stroke cases in Europe. In order to avoid disabling sequelae, an essential role is played by early rehabilitation, which has also proved effective for ICH. In addition to its role in physical recovery, it plays a fundamental role in the psychological well-being of patients with ICH. Impairments in trunk function are a common sequela and are related to reduced mobility, balance and functional independence. Trunk exercises could improve trunk control, postural control, and functional recovery. The hypothesis is that a specific exercise program, based on core stability, will induce clinically significant and long-term improvements from the point of view of trunk control, and secondly in postural control, disability and quality of life in subjects with hemorrhagic stroke outcomes, versus general physiotherapy, and that these improvements will be maintained at least one year after the intervention.


Description:

Stroke is responsible for about 7% of disabilities in the European population, and in particular intracerebral hemorrhage (ICH), whose mortality is higher than ischemic stroke, represents 15% of stroke cases in Europe. In order to avoid disabling sequelae, an essential role is played by early rehabilitation, which has also proved effective for ICH. Patients undergoing early rehabilitation within neurorehabilitation units achieve better clinical-functional outcomes than those who receive general medical care; furthermore, in addition to its role in physical recovery, it plays a fundamental role in the psychological well-being of patients with ICH, as these patients tend to be less depressed and anxious than those undergoing standard care. However, even after intensive rehabilitation functional deficits still exist, making stroke the leading cause of disability in adults globally. Impairments in trunk function, in particular, are a common sequelae and are related to reduced mobility, balance and functional independence. Therefore, impairments in trunk function can lead to limitations of activity and participation, as well as to increase the risk of falling resulting in further disability, hospitalization and mortality. The dysfunction of the core, which would significantly affect the function of the trunk, would seem to be linked to a reduction in muscle strength, to a delayed/asymmetrical activation of the muscles, as well as to proprioceptive alterations. Following this line, trunk exercises could then improve trunk control, postural control, and functional recovery. Looking at the literature, it has been seen how several randomized controlled trials have focused on the efficacy of trunk training in stroke populations with positive and encouraging results regarding the outcomes achieved within the experimental groups. However, these studies, in addition to including patients with both ischemic and haemorrhagic stroke, did not always equalize the amount of exercise provided with a control group, showing heterogeneity in the exercises administered, and did not consider whether the therapeutic efficacy observed at the end of the treatment is still maintained over the long term. The hypothesis is that a specific exercise program, based on core stability, will induce clinically significant and long-term improvements from the point of view of trunk control, and secondly in postural control, disability and quality of life in subjects with hemorrhagic stroke outcomes, versus general physiotherapy, and that these improvements will be maintained at least one year after the intervention.


Recruitment information / eligibility

Status Suspended
Enrollment 86
Est. completion date December 30, 2024
Est. primary completion date June 30, 2023
Accepts healthy volunteers No
Gender All
Age group 40 Years to 75 Years
Eligibility Inclusion Criteria: - haemorrhagic stroke < 3 months, first event - adulthood (40-75 years) - ability to maintain the sitting position - good knowledge of the Italian language Exclusion Criteria: - cognitive impairment - Ashworth score> 2 - Neurodegenerative and/or neuromuscular disorders - Severe cardiovascular and respiratory instability, systemic diseases

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Interventional programme
90-minute session divided into: 45 minutes of "core stability" treatment 45 minutes of general rehabilitation (active / active, assisted / passive mobilization, stretching, posture maintenance, postural and autonomy training, cycle ergometer, exercise bike and ambulatory training).
General exercise programme
90 minutes of general rehabilitation (active / active assisted / passive mobilization, stretching, posture maintenance, postural and autonomy training, cycle ergometer, exercise bike and ambulatory training).

Locations

Country Name City State
Italy University of Cagliari Cagliari

Sponsors (1)

Lead Sponsor Collaborator
University of Cagliari

Country where clinical trial is conducted

Italy, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change from Baseline Trunk Impairment Scale at 8 weeks and 12 months The Trunk Impairment Scale (TIS) is a 17-item scale that aims to assess the static, dynamic balance and coordination of the trunk. Each item is given a variable score from 0 to 3 in relation to the performance analyzed. The final score can range from a minimum of 0 points to a maximum of 23. The higher the score, the more independent the patient is in performing trunk control. Investigators used the Italian version which proved to be reliable and valid Questionnaires will be administered before treatment, eight weeks after (post-treatment) and 12 months after the end of treatment (follow-up)
Secondary Change from Baseline Functional Independence Measure (FIM) at 8 weeks and 12 months FIM describes 18 Activities of daily living (ADLs) associated with motor, cognitive, and sphincteral problems and ranges from 18 (maximal limitation) to 126 (no limitation).
Each item is scored on a 7 point ordinal scale, ranging from a score of 1 to a score of 7. The higher the score, the more independent the patient is in performing the task associated with that item.
Questionnaires will be administered before treatment, eight weeks after (post-treatment) and 12 months after the end of treatment (follow-up)
Secondary Change from Baseline Berg Balance Scale (BBS) at 8 weeks and 12 months It is a 14 item list with each item consisting of a five-point ordinal scale ranging from 0 to 4, with 0 indicating the lowest level of function and 4 the highest level of function Final score ranges from 0 (high risk of falling) to 56 (no risk of falling). Questionnaires will be administered before treatment, eight weeks after (post-treatment) and 12 months after the end of treatment (follow-up)
Secondary Change from Baseline Short-Form Health Survey Questionnaire at 8 weeks and 12 months Quality of life is assessed using the Italian version of the self-report Short-Form Health Survey with its eight domain scores ranging from 0 (the worst perceived quality of life) to 100 (the best perceived quality of life). Questionnaires will be administered before treatment, eight weeks after (post-treatment) and 12 months after the end of treatment (follow-up)
Secondary Global Perceived Effect Global Perceived Effect is a self-administered measure of treatment satisfaction consisting of a five-level Likert scale (1=helped a lot, 2=helped, 3=helped only a little, 4=did not help, 5=made things worse). eight weeks after starting treatment (post-treatment)
See also
  Status Clinical Trial Phase
Completed NCT03281590 - Stroke and Cerebrovascular Diseases Registry
Not yet recruiting NCT06026696 - Cohort of Neurovascular Diseases Treated in the Acute Phase and Followed at Lariboisière
Completed NCT01573117 - A Randomized Trial Comparing 2 Methods for Rapid Induction of Cooling in Stroke Patients, Cold Infusions vs. RhinoChill (iCOOL 1) Phase 2
Completed NCT03292211 - The Effect of Early Mobilization in Mild to Moderate Hemorrhagic Stroke N/A
Not yet recruiting NCT06069973 - Using Machine Learning and Biomarkers for Early Detection of Delayed Cerebral Ischemia
Not yet recruiting NCT05816213 - Point-of-care Low-field MRI in Acute Stroke
Not yet recruiting NCT05502874 - Multicenter Registry for Assessment of Markers of Early Neurological Deterioration in Primary Intracerebral Hemorrhage
Recruiting NCT04534556 - Wireless Nerve Stimulation Device To Enhance Recovery After Stroke N/A
Recruiting NCT04200781 - Clinical Evaluation of Shengdi Dahuang Decoction in the Treatment of Acute Hemorrhagic Stroke Phase 4
Recruiting NCT05440682 - Connectivity in Cranioplasty N/A
Completed NCT05121415 - Investigation of Genetic Disease Marker Associated With Spontaneous Haemorrhagic Stroke Complicating Severe Pre-eclampsia in Pregnancy
Terminated NCT02626377 - Multicenter Prospective Cohort of Informal Caregivers in Burgundy and Franche-Comté N/A
Completed NCT01942031 - Improved Prevention of Stroke in Primary Care in Stockholm, Sweden (Förbättrad Prevention av Stroke) N/A
Completed NCT01845350 - Safety of Autologous M2 Macrophage in Treatment of Non-Acute Stroke Patients Phase 1
Recruiting NCT05865795 - Mapping the Natural History of Parenychymal and Cerebral Perfusion Changes in Acute Ischemic and Hemorrhagic Strokes
Completed NCT04612218 - Biomarkers for Initiating Onsite and Faster Ambulance Stroke Therapies
Recruiting NCT06134921 - Effects of Transcranial Electrical Stimulation in Stroke Individuals N/A
Recruiting NCT06190314 - SERUM VITAMIN B12 LEVELS IN PATIENTS WITH HEMORRHAGIC VS ISCHEMIC CEREBROVASCULAR EVENT.
Recruiting NCT05735405 - Aerobic Exercise and Cognitive Training in Patients With Stroke N/A
Recruiting NCT06107725 - Maimonides Minocycline in Stroke Study Phase 2/Phase 3